cilengitide has been researched along with ganglioside, gd2 in 1 studies
| Studies (cilengitide) | Trials (cilengitide) | Recent Studies (post-2010) (cilengitide) | Studies (ganglioside, gd2) | Trials (ganglioside, gd2) | Recent Studies (post-2010) (ganglioside, gd2) |
|---|---|---|---|---|---|
| 194 | 29 | 133 | 421 | 30 | 171 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Horwacik, I; Rokita, H | 1 |
1 other study(ies) available for cilengitide and ganglioside, gd2
| Article | Year |
|---|---|
Modulation of interactions of neuroblastoma cell lines with extracellular matrix proteins affects their sensitivity to treatment with the anti-GD2 ganglioside antibody 14G2a.
Topics: Adenosine Triphosphate; Animals; Antibodies, Monoclonal; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Caspase 3; Cell Line, Tumor; Diterpenes; Extracellular Matrix Proteins; Gangliosides; Humans; Mice; Neuroblastoma; Small Molecule Libraries; Snake Venoms | 2017 |